A safe and effective treatment for MAS

Nature Reviews Rheumatology, Published online: 05 May 2023; doi:10.1038/s41584-023-00974-wPhase II trial results demonstrate rapid remission of macrophage activation syndrome in patients treated with the anti-IFNγ antibody emapalumab.

Source: Nature Reviews Rheumatology - May 5, 2023 Category: Rheumatology Authors: Robert Phillips Source Type: research